Best in class: General Pharmaceutical
What are the strongest names in one industry right now? One industry at a time, quality-ranked with the risk gate applied. Hubs with fewer than 8 covered names abstain rather than rank thin air.
| Symbol | Company | Why it's here |
|---|---|---|
| LLY | Eli Lilly and Company | Quality 91.1 · F-score 7 |
| NVS | Novartis AG | Quality 80.2 · Upside +20% · F-score 8 |
| AZN | AstraZeneca PLC | Quality 78.6 · F-score 7 |
| AMGN | Amgen Inc. | Quality 76.6 · Upside -1% · F-score 7 |
| GSK | GSK plc | Quality 74.6 · Upside +44% · F-score 8 |
| BMY | Bristol-Myers Squibb Company | Quality 67.2 · F-score 9 |
| SNY | Sanofi | Quality 65.0 · F-score 7 |
| NVO | Novo Nordisk A/S | Quality 59.4 · F-score 4 |
| GILD | Gilead Sciences, Inc. | Quality 58.4 · F-score 8 |
| GRFS | Grifols, S.A. | Quality 44.2 · F-score 6 |
Held out by the gates: JNJ (forensic flag), ABBV (negative equity), MRK (forensic flag), BIIB (forensic flag), AMRN (forensic flag), SCLX (forensic flag, negative equity, distress band High), MDCX (negative equity, distress band High). A held-out name is information, not a verdict — the flag and its source are on the stock page.
Ranked within General Pharmaceutical only — best-in-group, not a market call. QTick publishes measured descriptors and base rates. Publisher, not adviser.